Latest stories on COLL
Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
GlobeNewswire50 · neutralgeneral
Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
Business Insider50 · neutralgeneral
Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses
GlobeNewswire58 · neutralproduct/pr
Collegium resolves Nucynta patent dispute with Grünenthal
Seeking Alpha61 · neutralgeneral
Collegium Pharmaceutical Settles Nucynta ER Patent Dispute
TipRanks61 · neutralgeneral
Collegium discloses settlement agreement with Grunenthal
The Fly58 · neutralgeneral
COLLEGIUM PHARMACEUTICAL, INC (COLL) files 8-K
SEC 8-K42 · neutralgeneral
Collegium Pharmaceutical: Under 3x Cash Earnings After A Narrow Guidance Cut
Seeking Alpha58 · neutralanalyst
Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life
Business Insider56 · neutralproduct/pr
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform
Investing.com Analyst Ratings61 · neutralanalyst
Collegium Pharmaceutical initiated with an Outperform at Oppenheimer
The Fly63 · neutralanalyst
Collegium Pharmaceutical, Inc. (COLL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Leerink bullish on Collegium Pharmaceutical, initiates with an Outperform
The Fly61 · neutralanalyst
Collegium Pharmaceutical initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
Collegium Pharmaceutical assumed with a Buy at Truist
The Fly63 · neutralanalyst
Collegium to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Collegium to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays
The Fly38 · neutralanalyst
Why is Collegium Pharmaceutical stock climbing today?
Investing.com Markets50 · neutralgeneral
Collegium Pharmaceutical stock jumps on $50M share buyback
Investing.com Markets71 · bullishgeneral
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Collegium Pharmaceutical Launches $50 Million Accelerated Share Buyback
TipRanks71 · bullishgeneral
Collegium gains on $50M accelerated share buyback program
Seeking Alpha71 · bullishgeneral
COLLEGIUM PHARMACEUTICAL, INC (COLL) files 8-K
SEC 8-K50 · neutralgeneral
Collegium Announces $50 Million Accelerated Share Repurchase Program
GlobeNewswire71 · bullishgeneral